TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in
Antoni Ribas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.